Xinqiang Technology
Series A in 2025
Xinqiang Technology is a digital full-stack solution provider specializing in integrated solutions that combine hardware, software, cloud services, and artificial intelligence (AI) tailored for traditional industries.
Syngenta
Debt Financing in 2024
Syngenta, headquartered in Basel, Switzerland, is a global leader in agribusiness, dedicated to sustainable agriculture and improving food security. With over 28,000 employees in 90 countries, Syngenta develops and provides a wide range of crop protection products, including insecticides, fungicides, and herbicides, as well as bio-based solutions and genetically modified seeds. These products aim to enhance crop yields, increase resilience to environmental stresses, and minimize the use of natural resources. Syngenta's venture capital arm, Syngenta Group Ventures, established in 2009, invests in agriculture and food technology startups, supporting innovation in the sector. The firm is stage-agnostic, typically investing alongside other financial and corporate venture capital investors, and often takes board or board observer roles to support its portfolio companies.
Galaxy Bot
Venture Round in 2024
Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
Sinogene is a biotechnology company that specializes in pet cloning using somatic cell nuclear transfer technology. The company's team comprises scientists, doctors, and veterinary specialists who aim to advance animal genetic research through their services. Sinogene focuses on cloning and breeding various types of dogs, including working, pet, and purebred noble breeds, as well as preserving somatic cells' genes for future use in pet cloning and gene editing services.
Hangzhou Times Electric Technology
Series A in 2023
Times Electric is a developer of new energy vehicles and core components.
Thor Innovation
Series A in 2023
Thor Innovation is a high-tech enterprise focused on haptic technology, which provides electronic simulations of tactile sensations. The company specializes in developing and manufacturing haptic solutions for various industries, including consumer electronics, automotive, and healthcare. Thor Innovation's wide-band haptic technology and integrated solutions are designed to deliver immersive experiences that enhance extended reality and digital interactions through realistic physical feedback. This approach allows consumers to engage more fully with their devices, resulting in a more authentic and engaging user experience.
Chilye
Venture Round in 2022
Chilye is a company specializing in high-power electronic components and high-voltage connectors, primarily for the new energy vehicle sector. It offers a range of products including power distribution units, manual service disconnectors, charging and swapping connectors, and portable charging equipment. Chilye is dedicated to advancing the development of high-voltage electrical units aimed at supporting alternative energy vehicles. Through its focus on technical research and development, the company provides comprehensive solutions for complete vehicle systems, catering to the growing demand for innovative technologies in the electric vehicle market.
GalaxySpace
Series D in 2022
GalaxySpace is a Chinese company established in 2016, specializing in the development and manufacturing of low Earth orbit (LEO) broadband satellite constellations and 5G communication networks. The company focuses on creating satellite internet solutions and is engaged in the research, development, and production of various communication payloads and satellite platforms. Its product offerings include microwave communication payloads, phased array antennas, power management systems, and solar panels. Additionally, GalaxySpace provides comprehensive AI-driven satellite launch services, enabling clients to access efficient communication and information services at lower costs. The company's satellite applications extend to monitoring airport traffic, parking, and oil reserves, as well as evaluating land types and uses.
Origin Quantum
Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China, established in 2017. The company focuses on the development, promotion, and application of quantum computing technologies. Its offerings include quantum chips, measurement and control systems, and quantum software, which encompasses both content and various algorithms. Additionally, Origin Quantum provides a quantum computing cloud service platform, facilitating broader access to quantum technologies beyond laboratory environments. The company is dedicated to advancing the engineering and industrialization of quantum computing, aiming to accelerate its practical applications across various sectors in China.
Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.
MiRXES Pte. Ltd., founded in 2014 and based in Singapore, specializes in life science research tools and molecular diagnostic tests for both research and clinical applications. The company has developed a leading microRNA (miRNA) detection assay platform designed to identify cancer at asymptomatic stages. Its product offerings include RT-qPCR assays, assay panels, spike-in RNA kits, and solutions for biomarker discovery. By focusing on early cancer detection, MiRXES provides healthcare professionals with essential diagnostic tools to improve clinical outcomes through timely intervention.
Tianbing Technology
Series B in 2022
Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meet cost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system.
Keydom is the provider of smart card industry application solution services.
Moore Threads
Series A in 2021
Moore Threads, founded in 2020 and located in Beijing, China, specializes in the development of Graphics Processing Unit (GPU) technology tailored for various applications, including visual computing, artificial intelligence, and high-performance computing. The company provides advanced GPU technology and services to corporate clients across multiple sectors, such as gaming and the creative industry. Its offerings include solutions for data centers, edge computing servers, professional workstations, and high-performance personal computers, allowing clients to execute complex computational tasks efficiently.
Wego is a manufacturer of producing safe and affordable medical equipment.
Zhejiang Hozon New Energy Automobile Co., Ltd., founded in 2014 and headquartered in Tongxiang, China, specializes in the design and manufacture of electric vehicles. The company produces models such as the Nezha U, Nezha N01, and Eureka 02, focusing on integrating innovative technology through research and development. Hozon emphasizes intelligent manufacturing and multi-channel sales services, aiming to deliver high-quality, cost-effective intelligent electric vehicles. By prioritizing advancements in electricity, intelligence, and connectivity, Hozon seeks to enhance the user experience, providing a simple, intuitive, and comfortable mode of transportation. The company also maintains research and development centers in both China and the United States.
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.
IASO Biotherapeutics
Series C in 2021
Nanjing IASO Biotherapeutics is a clinical stage biotechnology company founded in 2017 and based in Nanjing, China. The company specializes in the discovery, development, and commercialization of innovative therapies for cancer, particularly through engineered autologous and allogenic T cell therapies. These therapies are designed to enhance the immune system's ability to recognize and eliminate cancer cells, positioning IASO Biotherapeutics as a key player in the oncology field.
Orbusneich Medical
Series B in 2021
OrbusNeich Medical is a leading global manufacturer of medical devices specializing in endovascular interventional instruments. Established in 2001 with its first research base, the company has developed a comprehensive portfolio of vascular solutions that are recognized for setting industry benchmarks in vascular intervention. As of 2023, OrbusNeich generates a significant portion of its revenue from Japan, followed closely by regions in Europe, the Middle East, and Africa. The company’s primary product offering is in the coronary interventional segment, which includes scoring balloons, non-compliant balloons, and stents, collectively accounting for the majority of its revenue. OrbusNeich's commitment to innovation and quality positions it as a key player in the medical device industry.
Kuaikan Manhua
Series F in 2021
Kuaikan Manhua is an online and mobile platform for original online comic artwork targeting young readers. Founded in 2014, Kuaikan Manhua is a comic-reading platform and community of interest that is popular among users. As of January 2019, the total number of users of the comics app is over 170 million, and the monthly users are over 40 million, and the market share in the comics market is more than half*. Kuaikan World’s vision is to build an ideal ecosystem of cultural-entertainment in the future, as well as bring happiness to the world. Kuaikan aims to help comic creators to create more widely-popular comics with positive, energetic and warm contents to millions of users.
Beijing Health Guard Biotechnology
Private Equity Round in 2021
Beijing Health Guard Biotechnology is a research and development firm based in Beijing, China, founded in 2008. The company focuses on the development of recombinant protein drugs and vaccines for the biotech industry. Its primary emphasis is on the research and industrialization of recombinant protein vaccines, particularly human papillomavirus (HPV) vaccines. Beijing Health Guard Biotechnology is advancing several innovative candidate vaccines targeting various infectious diseases, with its core pipeline featuring both trivalent and nonavalent HPV vaccines. The company employs a structure-guided design approach in its biopharmaceutical research and development efforts.
SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energy vehicle charging piles, batteries recycling, and solutions.
Beijing Gene+ Technology
Series C in 2021
Beijing Gene+ Technology, founded in 2015 and based in Beijing, China, specializes in gene testing services aimed at cancer prevention and early detection. The company provides a range of services, including clinical testing, medical device manufacturing, and scientific cooperation related to precision medicine. Operating in approximately 100 hospitals, Beijing Gene+ Technology has supported thousands of cancer patients across the country, contributing to advancements in personalized healthcare and tumor treatment strategies.
Geneplus-Beijing
Series C in 2021
Geneplus Co.,Ltd. is a market leader in biotechnology and molecular diagnostic distribution. The company is primarily concerned with molecular biological solutions for Applied Life Science and Molecular Diagnostics.
Shanghai Cell Therapy Group
Series D in 2021
Shanghai Cell Therapy Group Co., Ltd. is a leading entity in the healthcare sector, specializing in cell therapy technology since its establishment in 2013 in Shanghai, China. The company provides a comprehensive range of services, including technical consulting, technology transfer, and investment in the field of cell therapy. It operates a cellular diagnosis center that integrates cellular research with treatment services, focusing on the development of tumor immune cell therapy. Additionally, Shanghai Cell Therapy Group is engaged in cellular cold storage, the production of cellular pharmaceuticals, antibody research, and facilitating genetic testing for patients, while also supplying valuable research data to cancer facilities.
Didi Woya
Series A in 2021
Didi Woya is a pioneering startup focused on creating autonomous vehicles for rideshares. Their goal is to revolutionize transportation services by providing efficient, affordable, and comfortable rides with rapid response times and budget-friendly fares. Utilizing cutting-edge technologies such as machine learning, the Internet of Things, and comprehensive 360-degree monitoring, DiDi Woya is dedicated to developing and commercializing innovative solutions in the field.
Youyun
Debt Financing in 2020
Youyun is the designer of a full-stack operation and maintenance service platform aimed at increasing company efficiency. They specialize in creating a variety of cloud-based business software solutions that increase the effectiveness of enterprise management and maintenance while enabling quick and efficient digital transportation for a range of sectors.
Biostar Technologies
Series E in 2020
Beijing Biostar Technologies, Ltd., established in 2002, is a biopharmaceutical company based in Beijing, China. It specializes in the development of anti-tumor chemotherapy biopharmaceutical molecules, with a focus on creating innovative small molecule chemical drugs for cancer treatment. The company was founded by a team of Chinese scientists led by Dr. Tang Li and Dr. Qiu Rongguo, who previously worked in the United States. Biostar Technologies pioneered the creation of new anti-cancer drugs based on epothilone in China and its technology is recognized as being at the international advanced level.
UtmoLight
Seed Round in 2020
UtmoLight is engaged in the research, development, and manufacture of perovskite-based photovoltaic and optoelectronic products. The company specializes in a range of technologies, including perovskite solar cells, light-emitting quantum dots, and the industrialization of perovskite technology. UtmoLight focuses on synthesizing high-quality perovskite quantum dots that cover the full visible spectrum, as well as developing enhanced filter films utilizing these quantum dots. By delivering innovative solutions in the photovoltaic sector, the company aims to provide clients with advanced materials derived from calcium titanium ore for various applications in the photoelectric field.
Hinova Pharma
Series C in 2020
Hinova Pharmaceuticals Inc. is a drug discovery and development company based in Chengdu, China, with additional branches in Hong Kong, Texas, and Australia. Established in 2013, the company specializes in the research and manufacturing of innovative medicines to address unmet medical needs, particularly in oncology and metabolic diseases. Utilizing advanced technology platforms such as deuterium and PROTAC, Hinova develops both Best-in-class and First-in-class drugs. Its product pipeline includes the HC-1119 androgen receptor antagonist and HC-1102 androgen receptor inhibitors, which target advanced prostate cancer and breast cancer. The company's commitment lies in providing safe, effective, and affordable treatments while retaining global rights and interests in its drug portfolio.
Sinovent, established in 2016, is a global biopharmaceutical company with headquarters in Suzhou, China, and offices in Beijing, China, and Boston, U.S.A. It specializes in developing advanced treatments for global healthcare challenges, with a focus on oncology, autoimmune diseases, and infectious diseases. Sinovent's portfolio comprises 12 products in various stages of development, leveraging its expertise in science, management, and finance to deliver innovative solutions to patients worldwide.
Thousand Oaks Biopharmaceuticals
Series B in 2020
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.
Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.
Intellifusion
Series C in 2020
Shenzhen Intellifusion Technologies Co., Ltd. is a technology company founded in August 2014, specializing in artificial intelligence and chip technology. The company focuses on developing core products, including algorithm software and chips, aimed at structuring the physical world through AI to create digital twin cities. Intellifusion's comprehensive AI technology platform supports various applications in public safety, social governance, new business, and AIoT. Its innovative solutions have been implemented across numerous cities in China, including Shenzhen, Beijing, and Shanghai, as well as in Southeast Asia and over 100 other regions. Intellifusion is backed by a team of international experts dedicated to advancing AI technology for diverse societal needs.
Immunocore
Series B in 2020
Immunocore Limited is a biotechnology company based in Abingdon, United Kingdom, with an additional office in Conshohocken. Founded in 1999, the company focuses on the discovery and development of innovative T cell receptor-based therapeutics aimed at addressing significant unmet medical needs in cancer, viral diseases, and autoimmune diseases. Immunocore specializes in engineering T cell receptors (TCRs) and linking them to antibody fragments, which has led to the development of its lead product candidate, IMCgp100, currently undergoing clinical trials for metastatic melanoma. The company's proprietary TCR technology platform is validated and designed for efficient manufacturing, supporting both clinical and commercial supply. Immunocore was previously known as Avidex Limited before adopting its current name in 2008.
Suzhou Kintor Pharmaceuticals
Series D in 2019
Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.
Chengjia Apartment
Series A in 2019
Chengjia Apartment is a rental start-up based in Shanghai, China, that offers a variety of accommodation options including apartments, hotels, and homestays. Founded in 2015, the company provides flexible rental terms ranging from weekly to long-term stays, catering to diverse customer needs. Chengjia Apartment focuses on creating a high-quality living environment, combining the comforts of home with hotel-style services to ensure a warm and comfortable experience for its guests. The business has expanded significantly, managing nearly 100 properties across major cities in China and offering over 10,000 houses and related services. Chengjia Apartment is jointly established by China Living Hotel Group and IDG Capital, reflecting a strong partnership in the hospitality sector.
Boston Micro Fabrication
Series A in 2019
Boston Micro Fabrication is a micro-scale 3D printing system manufacturer dedicated to the development of micro-scale 3D printing systems and functional composites. used in microfluidics, medical devices, electronics, and education.
Vapo Health
Series A in 2019
Vapo Health is a medical device company based in Kunshan City, China, focused on developing, manufacturing, and distributing products for respiratory system health. Established in 2015, the company employs advanced nano-scale atomized micro-hole technology to enhance drug delivery and particle efficiency in its offerings. Its product range includes nebulizers, spacers, thermometers, intelligent breathing trainers, and aerosol devices, as well as OEM and ODM services. Vapo Health aims to provide innovative and effective solutions to support respiratory health recovery and improve patient outcomes.
Inspur Cloud
Series B in 2019
Inspur Cloud, established in 2010 with headquarters in Jinan, China, specializes in providing global datacenter and cloud computing solutions. It offers a range of hardware including servers and storage systems, along with software solutions such as artificial intelligence and high-performance computing platforms. Inspur Cloud caters to diverse clients, including governments, enterprises, and industries, aiming to enhance their transparency and efficiency through secure digital transformation.
Emirates National Oil Company
Debt Financing in 2019
Emirates National Oil Company (ENOC), established in 1993 and wholly owned by the Dubai Government, plays a pivotal role in the economic diversification and sustainable development of the United Arab Emirates. Based in Dubai, ENOC focuses on both upstream and downstream activities in the oil and gas sector. Over the years, the company has diversified its operations, expanding into various high-growth sectors to generate long-term value for its stakeholders while providing oil and gas services to clients worldwide.
Momenta is an autonomous driving startup based in Beijing that specializes in developing advanced software solutions for full autonomy in vehicles. The company leverages deep learning technologies for perception, high-definition semantic mapping, and data-driven path planning, providing multi-level autonomous driving solutions alongside big data products and services. Momenta's team includes leading experts in computer vision and deep learning, contributing to the company's innovative approach to autonomous driving. Their technology is designed to enhance driving efficiency and safety, aiming to improve the overall experience for users through artificial intelligence.
Pengyang Medical
Series A in 2018
Pengyang Medical specializes in the development of medical monitoring hardware and information products, with a particular focus on electrocardiogram (ECG) artificial intelligence technology. The company aims to enhance cardiovascular diagnostic services by integrating advanced technologies with medical resources. Through research and development, Pengyang Medical creates innovative ECG solutions that provide detailed insights into patients' cardiovascular health, helping practitioners to improve diagnostic accuracy and reduce the likelihood of misdiagnoses.
Suning.com
Series A in 2018
Suning.com is a prominent Chinese online shopping platform that offers a wide range of products, including clothing, snacks, electronics, and appliances. The company emphasizes a comprehensive retail experience by integrating smart retail solutions with full category operations and omni-channel services, enabling customers to shop seamlessly through physical stores, mobile devices, PCs, and TVs. Additionally, Suning.com leverages logistics and global expansion strategies to enhance its service offerings. Founded in 1990, Suning Holdings Group, which includes Suning.com, has established itself as a leading commercial enterprise in China, recognized for its significant annual revenue and diverse business interests across various sectors, including logistics, financial services, and media. Suning's commitment to improving the quality of life through technological advancements and innovative retail solutions underscores its influence in the retail landscape.
Ascentage Pharma
Series C in 2018
Ascentage Pharma Group International is a clinical-stage biotechnology company focused on developing novel small-molecule therapies for cancer, hepatitis B virus (HBV), and age-related diseases. Founded in 2009 and headquartered in Suzhou, China, the company has established a diverse pipeline of drug candidates, including HQP1351, a BCR-ABL/KIT inhibitor targeting resistant mutations, and APG-2575, an orally administered Bcl-2 selective inhibitor for hematologic malignancies. Additional candidates include APG-1252, aimed at restoring apoptosis in various solid tumors, and APG-115, which targets the MDM2-p53 interaction in solid tumors and lymphoma. Ascentage Pharma also develops APG-1387 for advanced solid tumors and chronic HBV infection, alongside other therapies for non-small-cell lung carcinoma and chronic lymphocytic leukemia. The company has entered into clinical collaborations to explore innovative treatment combinations, furthering its commitment to addressing challenging diseases in the oncology landscape.
Blocksteam
Series A in 2018
Blocksteam is a Gaming company.
LLVISION was founded in 2014 by an elite team from Google, Lenovo, Microsoft, Intel, China Aeronautics, Nokia, Broadcom, etc.Their mission is to help the industry leaders intellectualize business processes through the first perspective innovation linked with multi-dimension connections, cognition and synergy and upgraded human-machine collaboration.
8Trip, a China-based online travel service which connects suppliers with sellers. Currently, 8Trip covers the markets of Wuxi, Nanjing, and Anhui in China, and is planning to enter the Shanghai market next year. The company has partnerships with about 1,000 travel agencies and more than 4,000 service outlets. 8Trip was founded in December 2011 under the company name Octopus Online Tourism Development, with headquarters in Suzhou.
Oxford Nanopore Technologies
Venture Round in 2018
Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.
Innocare
Venture Round in 2018
InnoCare is a biopharmaceutical company based in China, focused on the discovery and development of innovative treatments for cancer and autoimmune diseases. The company boasts a highly skilled scientific team with extensive drug innovation experience in both the United States and China, supported by a distinguished Scientific Advisory Board composed of experts from top universities, hospitals, and the pharmaceutical industry. InnoCare's product pipeline includes a range of therapies, such as orelabrutinib, zanubrutinib, and tafasitamab, targeting hematological tumors, solid tumors, and autoimmune diseases. The company aims to make significant advancements in the treatment of conditions related to abnormal B-cell and T-cell functions, thereby contributing to the global fight against these diseases.
Chezhency.com
Series B in 2018
Chezhency.com is a B2B auto trading platform based in Shenzhen, China, founded in 2015. The company specializes in integrating various services related to the automotive industry, including automotive logistics, supply chain finance, consumer credit, and automobile insurance. By unifying these services, Chezhency.com aims to streamline the trading process for businesses involved in the automotive sector, enhancing efficiency and facilitating smoother transactions.
Suzhou Kintor Pharmaceuticals
Series C in 2018
Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.
ByteDance
Series D in 2017
ByteDance is a technology company that develops and operates a range of content platforms, most notably TikTok and Douyin. It aims to enhance user experiences through innovative technology, allowing individuals to connect, create, and consume content seamlessly. The company specializes in mobile applications that cater to online media, entertainment, and social networking, leveraging artificial intelligence to deliver personalized content that aligns with users' preferences. In addition to its flagship platforms, ByteDance provides tools that facilitate content creation and collaboration, reflecting its commitment to enriching lives through technology.
CooTek, founded in 2008 and headquartered in Shanghai, is a global mobile internet company that specializes in developing innovative mobile applications and artificial intelligence technologies. The company is best known for its flagship app, TouchPal Keyboard, which enhances input experiences for users on both Android and iPhone devices. CooTek's diverse portfolio includes content-rich applications across various categories, such as online literature, mobile games, and scenario-based apps focused on fitness, healthcare, and lifestyle. With a significant presence in the United States, CooTek has achieved a broad user base, boasting an average of 213.7 million monthly active users globally as of September 2018. The company is committed to technological innovation, holding over 170 patents and actively pursuing advancements in artificial intelligence through its dedicated AI lab and big data development center in Silicon Valley. CooTek's research has been recognized in prominent discussions at major big data and AI conferences.
Sooner
Angel Round in 2017
Sooner develops video technology products and services.
Megvii, founded in 2011, is an artificial intelligence company that specializes in intelligent solutions and data services for enterprises and developers. The company is focused on its mission to create machines capable of seeing and thinking, leveraging its deep learning system, Brain++. Megvii aims to build a comprehensive AI engine that serves as the foundational technology for various applications. It connects standardized hardware, such as sensors and personal devices, with artificial intelligence and the Internet of Things (AIoT), commercializing three main application areas: Consumer IoT, City IoT, and Supply Chain IoT. By integrating hardware and software solutions, Megvii enables clients to efficiently establish AI infrastructure tailored to their needs, positioning itself as an expert in AIoT solutions.
Shouqi Car Rental
Venture Round in 2016
Shouqi Car Rental is a car rental service and a subsidiary of Shouqi Group, a transportation company headquartered in China. It provides both business-to-business and business-to-consumer car rental solutions for institutional and individual customers. The company specializes in offering short-term and long-term rental options, allowing users to access vehicles on-demand by the hour or day. Shouqi Car Rental operates in various locations, including cities and airports within China and internationally, facilitating convenient transportation for its clientele.
Firstp2p is an online lending information platform based in Beijing, China, established in 2013. The company connects individual investors with small and medium enterprises that are unable to access traditional bank financing. Through its platform, Firstp2p offers a range of financial products, including car loans, mortgages, and financial leasing solutions, aimed at supporting the needs of these businesses. This model allows Firstp2p to facilitate alternative financing options while providing investors with opportunities to engage in direct lending.
Firefly Games
Venture Round in 2016
Firefly Games Inc. is a mobile game developer and publisher founded in 2014 and headquartered in Los Angeles, California, with additional offices in Shanghai and other regions. The company specializes in creating community-focused mid-core and hardcore games for iOS and Android platforms, with a portfolio that includes titles such as Tourivia, Battle Hatchers, Fury Fables, and DreamWorks Universe of Legends. Firefly Games emphasizes continuous development and regular updates for its story-based games, fostering an engaging experience for players. The talented team at Firefly Games comprises industry veterans from notable companies, reflecting a deep commitment to quality and innovation in gaming. In addition to mobile gaming, the company also explores opportunities in virtual reality and e-sports, aiming to connect gamers and enhance their gaming experiences on a global scale. Firefly Games operates as a subsidiary of Riva Technology and Entertainment Limited.
Weidong Cloud Education
Venture Round in 2016
Weidong Cloud Education Group is focused on bridging the educational divide between various regions by enhancing education through technology. The company develops an internet-based educational ecosystem that offers a wide range of courses, including basic, vocational, and international education in sectors such as finance, management, medicine, and technology. Utilizing integrated "Cloud + Client" solutions, the company collaborates with leading global enterprises in software and hardware to create a comprehensive public service platform for educational resources. This initiative includes the establishment of a cloud data center and the Weidong International Education Cloud Industrial Park in Qingdao's Blue Silicon Valley, aimed at delivering high-quality educational services worldwide.
Ant Group
Series B in 2016
Ant Group Co., Ltd. is a leading provider of digital payment and financial services in China, known for its flagship product, Alipay, a widely used digital payments platform. Established in 2000 and headquartered in Hangzhou, the company offers a variety of financial solutions, including Yu'e Bao, an online cash management platform that invests users' funds in a money market fund; Huabei, a consumer credit service facilitating buy now, pay later options; and MYbank, an online bank focused on serving small businesses and entrepreneurs. Additionally, Ant Group operates Xiang Hu Bao, a mutual aid platform for health protection, and Zhima Credit, a credit assessment service for businesses. The company aims to foster digital transformation across the service industry, ensuring that consumers and small enterprises have equal access to inclusive and sustainable financial services. In July 2020, it rebranded from Ant Small and Micro Financial Services Group Co., Ltd. to Ant Group Co., Ltd.
Wellong Etown
Venture Round in 2016
Wellong Etown allows the clients to travel by car and ship all over the world, with high income and low cost for finding online smart load. Huilong installs a satellite positioning terminal for you with low fees and good service. The company finds empty trucks for your goods to be transported. It also transports online dispatching calls with high efficiency and punctuality.
Phylion Battery
Series A in 2015
Phylion Battery is a manufacturer based in Suzhou, China, specializing in the development, production, and sales of lithium-ion batteries. Utilizing lithium manganate as its positive electrode material, the company has established an annual production capacity of 5GWh. With over 15 years of experience in technology transformation, Phylion has successfully served 8 million end users and provided battery solutions for more than 45,000 electric vehicles globally. The company is recognized as a high-tech enterprise in the power lithium battery sector and is actively involved in research and development within the energy storage field. Phylion is committed to delivering innovative power supply solutions for new energy vehicles and various industrial applications worldwide.
XYWY.com is an online platform dedicated to providing a range of medical services to users. The platform enables individuals to search for medical professionals and access free consultations, facilitating the acquisition of medical information and diagnoses. In addition to these services, XYWY.com offers appointment registration and guidance for drug searches and shopping, allowing clients to manage their healthcare needs efficiently through a single interface. By streamlining access to medical resources, XYWY.com aims to enhance the healthcare experience for patients.
Firstp2p is an online lending information platform based in Beijing, China, established in 2013. The company connects individual investors with small and medium enterprises that are unable to access traditional bank financing. Through its platform, Firstp2p offers a range of financial products, including car loans, mortgages, and financial leasing solutions, aimed at supporting the needs of these businesses. This model allows Firstp2p to facilitate alternative financing options while providing investors with opportunities to engage in direct lending.
Taikang Bybo Dental
Series B in 2012
Taikang Bybo Medical Group is a prominent national dental medical group in China, specializing in comprehensive oral healthcare services for middle and upper-income demographics. The company is committed to delivering high-quality dental treatments and preventive care tailored to all age groups, aiming to enhance long-term oral health and overall well-being. By pursuing an exceptional customer experience and exploring innovative models in the dental sector, Taikang Bybo seeks to establish itself as the leading high-end dental chain brand in the country.
Galloping Horse
Private Equity Round in 2011
Beijing Galloping Horse Film & TV Production Co., Ltd. is a prominent company engaged in the production and distribution of films, television series, and advertising solutions. Founded in 2003 and based in Beijing, China, the company has established a strategic partnership with Digital Domain Media Group. Galloping Horse specializes in creating content that caters to the elite class in China, providing them with entertainment options for social gatherings. Through its comprehensive advertising and production services, the company plays a significant role in the Chinese entertainment industry.
Green Leader
Convertible Note in 2010
Green Leader Holdings Group Ltd is a mineral exploration and development company primarily focused on investments in the mining sector, with a significant presence in Mongolia. The company operates through four main segments: Mining Operations, which involves geological surveys, exploration, and the development and sale of coking coal; Systems Integration Services and Software Solutions, offering IT products, systems integration, technology services, and software development; Cassava Starch Operations, which focuses on the cultivation and processing of cassava starch for commercial sale; and Coal Operations, which specializes in coal trading. Through these diverse segments, Green Leader aims to leverage opportunities in both the mining and technology industries.